45 results on '"Poirel O"'
Search Results
2. Norfloxacin administration reduces aortic no overproduction through AKT signal transduction pathway in cirrhotic rats: OP-17
- Author
-
Tazi, K. A., Moreau, R., Poirel, O., and Lebrec, D.
- Published
- 2004
3. DISCREPANT REGULATION OF AORTIC NOS2 AND NOS3 IN TWO MODELS OF PORTAL HYPERTENSION DURING ENDOTOXEMIA
- Author
-
Heller, J., Sogni, P., Tazi, K. A., Chagneau, C., Poirel, O., Moreau, R., and Lebrec, D.
- Published
- 1999
4. P.5.b.005 Vesicular glutamate transporters in pathologies of the central nervous system
- Author
-
Lepicard, E., primary, Poirel, O., additional, Kashani, A., additional, Amilhon, B., additional, Hirsch, E., additional, Epelbaum, J., additional, David, J.P., additional, Delacourte, J., additional, Giros, B., additional, Betancur, C., additional, and El Mestikawy, S., additional
- Published
- 2007
- Full Text
- View/download PDF
5. 200 Norfloxacin administration reduces aortic nitric oxide synthase (NOSS) upregulation in cirrhotic rats: Role of proinflammatory cytokines and akt signaling pathway
- Author
-
Tazi, K.A., primary, Moreau, R., additional, Poirel, O., additional, and Lebrec, D., additional
- Published
- 2004
- Full Text
- View/download PDF
6. 194 Upregulation of toll-like receptor 4 (TLR4) is induced by lipopolysaccharide (LPS) to produce enhanced proinflammatory responses in monocytes from patients with cirrhosis
- Author
-
Tazi, K.A., primary, Poirel, O., additional, Lebrec, D., additional, and Moreau, R., additional
- Published
- 2004
- Full Text
- View/download PDF
7. Interaction between eNOS and iNOS in aortas and superior mesenteric arteries in portal hypertensive rats
- Author
-
Malyshev, E., primary, Poirel, O., additional, Moreau, R., additional, and Lebrec, D., additional
- Published
- 2003
- Full Text
- View/download PDF
8. Prevention of hepatopulmonary syndrome by pentoxifylline in rats with cirrhosis
- Author
-
Sztrymf, B., primary, Rabiller, A., additional, Moreau, R., additional, Poirel, O., additional, Mazmanian, M., additional, Le Pape, A., additional, Lebrec, D., additional, and Herve, P., additional
- Published
- 2003
- Full Text
- View/download PDF
9. Relationship between protein kinase C alterations and nitric oxide overproduction in cirrhotic rat aortas
- Author
-
Tazi, KA, primary, Barrière, E, additional, Moreau, R, additional, Poirel, O, additional, Lebrec, D., additional, Tazi, Khalid A., additional, Barrière, Eric, additional, Moreau, Richard, additional, Poirel, Odile, additional, and Lebrec, Didier, additional
- Published
- 2002
- Full Text
- View/download PDF
10. Terlipressin administration decreases iNOS expression and improves circulatory and liver dysfunction in endotoxin-challenged rats with cirrhosis
- Author
-
Barriere, E., primary, Tazi, K.A., additional, Poirel, O., additional, Lebrec, D., additional, and Moreau, R., additional
- Published
- 2001
- Full Text
- View/download PDF
11. Role of small-conductance calcium-dependent K+ channels in nitric oxide (NO)-mediated aortic hyporeactivity to vasoconstrictors in rats with cirrhosis
- Author
-
Barriere, E., primary, Tazi, K.A., additional, Pessione, F., additional, Heller, J., additional, Poirel, O., additional, Lebrec, D., additional, and Moreau, R., additional
- Published
- 2001
- Full Text
- View/download PDF
12. Pharmacological evidence that cytochrome P450 is an EDHF-synthase in the superior mesenteric arteries from rats with cirrhosis
- Author
-
Barriere, E., primary, Tazi, K.A., additional, Poirel, O., additional, Lebrec, D., additional, and Moreau, R., additional
- Published
- 2001
- Full Text
- View/download PDF
13. Association between aortic eNOS overactivation and enhanced shear stress in rats with cirrhosis
- Author
-
Tazi, K.A., primary, Barriere, E., additional, Heller, J., additional, Sogni, P., additional, Pateron, D., additional, Poirel, O., additional, Moreau, R., additional, and Lebrec, D., additional
- Published
- 2001
- Full Text
- View/download PDF
14. Inhibition of type 4 phosphodiesterase improves sodium excretion incirrhotic rats with ascites
- Author
-
Ahloulay, M., primary, Lugnier, C., additional, Moreau, R., additional, Le Bec, A., additional, Tazi, K.A., additional, Poirel, O., additional, and Lebrec, D., additional
- Published
- 2000
- Full Text
- View/download PDF
15. Impaired protein kinase C isoform translocation associated withvascular hyporeactivity in aortae from cirrhotic rats
- Author
-
Tazi, K.A., primary, Moreau, R., additional, Heller, J., additional, Poirel, O., additional, and Lebrec, D., additional
- Published
- 2000
- Full Text
- View/download PDF
16. Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to a-adrenergic vasoconstriction in rats with cirrhosis
- Author
-
Barriere, E., Tazi, K. A., Pessione, F., Heller, J., Poirel, O., Lebrec, D., and Moreau, R.
- Published
- 2001
- Full Text
- View/download PDF
17. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
- Author
-
Heller, J., Sogni, P., Barriere, E., Tazi, K. A., Chauvelot-Moachon, L., Guimont, M.-C., Bories, P. N., Poirel, O., Moreau, R., and Lebrec, D.
- Published
- 2000
- Full Text
- View/download PDF
18. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension
- Author
-
Chagneau, C., Tazi, K. A., Heller, J., Sogni, P., Poirel, O., Moreau, R., and Lebrec, D.
- Published
- 2000
- Full Text
- View/download PDF
19. 711 Pentoxifylline protects genetically obese mice from ethanol-induced hepatic apoptosis
- Author
-
Robin, M.A., Demeilliers, C., Sutton, A., Paradise, V., Maisonneuve, C., Dubois, S., Poirel, O., Lettéron, P., Pessayre, D., and Fromenty, B.
- Published
- 2006
- Full Text
- View/download PDF
20. Regulation of stress-induced sleep perturbations by dorsal raphe VGLUT3 neurons in male mice.
- Author
-
Henderson F, Dumas S, Gangarossa G, Bernard V, Pujol M, Poirel O, Pietrancosta N, El Mestikawy S, Daumas S, and Fabre V
- Subjects
- Animals, Male, Mice, Serotonin metabolism, Mice, Inbred C57BL, Amino Acid Transport Systems, Acidic metabolism, Amino Acid Transport Systems, Acidic genetics, Dorsal Raphe Nucleus metabolism, Stress, Psychological metabolism, Neurons metabolism, Sleep physiology
- Abstract
Exposure to stressors has profound effects on sleep that have been linked to serotonin (5-HT) neurons of the dorsal raphe nucleus (DR). However, the DR also comprises glutamatergic neurons expressing vesicular glutamate transporter type 3 (DR
VGLUT3 ), leading us to examine their role. Cell-type-specific tracing revealed that DRVGLUT3 neurons project to brain areas regulating arousal and stress. We found that chemogenetic activation of DRVGLUT3 neurons mimics stress-induced sleep perturbations. Furthermore, deleting VGLUT3 in the DR attenuated stress-induced sleep perturbations, especially after social defeat stress. In the DR, VGLUT3 is found in subsets of 5-HT and non-5-HT neurons. We observed that both populations are activated by acute stress, including those projecting to the ventral tegmental area. However, deleting VGLUT3 in 5-HT neurons minimally affected sleep regulation. These findings suggest that VGLUT3 expression in the DR drives stress-induced sleep perturbations, possibly involving non-5-HT DRVGLUT3 neurons., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
21. The human VGLUT3-pT8I mutation elicits uneven striatal DA signaling, food or drug maladaptive consumption in male mice.
- Author
-
Favier M, Martin Garcia E, Icick R, de Almeida C, Jehl J, Desplanque M, Zimmermann J, Henrion A, Mansouri-Guilani N, Mounier C, Ribeiro S, Henderson F, Geoffroy A, Mella S, Poirel O, Bernard V, Fabre V, Li Y, Rosenmund C, Jamain S, Vorspan F, Mourot A, Duriez P, Pinhas L, Maldonado R, Pietrancosta N, Daumas S, and El Mestikawy S
- Subjects
- Animals, Male, Mice, Humans, Acetylcholine metabolism, Substance-Related Disorders metabolism, Substance-Related Disorders genetics, Signal Transduction drug effects, Glutamic Acid metabolism, Interneurons metabolism, Interneurons drug effects, Feeding and Eating Disorders metabolism, Feeding and Eating Disorders genetics, Feeding and Eating Disorders physiopathology, Mice, Inbred C57BL, Amino Acid Transport Systems, Acidic metabolism, Amino Acid Transport Systems, Acidic genetics, Mutation, Mutation, Missense, Vesicular Acetylcholine Transport Proteins, Dopamine metabolism, Corpus Striatum metabolism
- Abstract
Cholinergic striatal interneurons (ChIs) express the vesicular glutamate transporter 3 (VGLUT3) which allows them to regulate the striatal network with glutamate and acetylcholine (ACh). In addition, VGLUT3-dependent glutamate increases ACh vesicular stores through vesicular synergy. A missense polymorphism, VGLUT3-p.T8I, was identified in patients with substance use disorders (SUDs) and eating disorders (EDs). A mouse line was generated to understand the neurochemical and behavioral impact of the p.T8I variant. In VGLUT3
T8I/T8I male mice, glutamate signaling was unchanged but vesicular synergy and ACh release were blunted. Mutant male mice exhibited a reduced DA release in the dorsomedial striatum but not in the dorsolateral striatum, facilitating habit formation and exacerbating maladaptive use of drug or food. Increasing ACh tone with donepezil reversed the self-starvation phenotype observed in VGLUT3T8I/T8I male mice. Our study suggests that unbalanced dopaminergic transmission in the dorsal striatum could be a common mechanism between SUDs and EDs., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
22. Nanoscopic distribution of VAChT and VGLUT3 in striatal cholinergic varicosities suggests colocalization and segregation of the two transporters in synaptic vesicles.
- Author
-
Cristofari P, Desplanque M, Poirel O, Hébert A, Dumas S, Herzog E, Danglot L, Geny D, Gilles JF, Geeverding A, Bolte S, Canette A, Trichet M, Fabre V, Daumas S, Pietrancosta N, El Mestikawy S, and Bernard V
- Abstract
Striatal cholinergic interneurons (CINs) use acetylcholine (ACh) and glutamate (Glut) to regulate the striatal network since they express vesicular transporters for ACh (VAChT) and Glut (VGLUT3). However, whether ACh and Glut are released simultaneously and/or independently from cholinergic varicosities is an open question. The answer to that question requires the multichannel detection of vesicular transporters at the level of single synaptic vesicle (SV). Here, we used super-resolution STimulated Emission Depletion microscopy (STED) to characterize and quantify the distribution of VAChT and VGLUT3 in CINs SVs. Nearest-neighbor distances analysis between VAChT and VGLUT3-immunofluorescent spots revealed that 34% of CINs SVs contain both VAChT and VGLUT3. In addition, 40% of SVs expressed only VAChT while 26% of SVs contain only VGLUT3. These results suggest that SVs from CINs have the potential to store simultaneously or independently ACh and/or Glut. Overall, these morphological findings support the notion that CINs varicosities can signal with either ACh or Glut or both with an unexpected level of complexity., Competing Interests: SDu was employed by Oramacell. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Cristofari, Desplanque, Poirel, Hébert, Dumas, Herzog, Danglot, Geny, Gilles, Geeverding, Bolte, Canette, Trichet, Fabre, Daumas, Pietrancosta, El Mestikawy and Bernard.)
- Published
- 2022
- Full Text
- View/download PDF
23. Effects of pupillary reflex dilation-guided opioid administration on remifentanil and morphine consumption during laparoscopic surgery: A randomised controlled trial.
- Author
-
Guerci P, Jay G, Arnout C, Herbain D, Baka N, Poirel O, Novy E, Bouaziz H, and Vial F
- Subjects
- Dilatation, Double-Blind Method, Humans, Morphine, Pain, Postoperative diagnosis, Pain, Postoperative prevention & control, Reflex, Pupillary, Remifentanil, Single-Blind Method, Analgesics, Opioid, Laparoscopy
- Abstract
Background: Analysis of pupillary reflex dilation (PRD) assesses the balance of nociception--antinociception. Laparoscopic surgery induces haemodynamic variations that are misleading. During laparoscopy, PRD guidance helps differentiate haemodynamic changes because of excess nociception from secondary changes related to the reflex release of endocrine factors., Objective: The present study evaluated the effect of PRD-guided antinociception on the administration of intra-operative remifentanil and immediate postoperative morphine consumption in patients undergoing elective laparoscopic surgery., Design: The study was a single-blind, randomised controlled trial., Setting: The study took place at two sites at the University Hospital of Nancy from March 2014 to November 2017., Patients: A total of 100 patients who underwent scheduled laparoscopic surgery were included., Interventions: Patients were randomly given remifentanil guided by PRD (PRD-guided) or standard anaesthesia care (control)., Main Outcome Measures: The primary outcome was intra-operative remifentanil consumption. Secondary outcomes included morphine consumption in the immediate postoperative period and the number of intra-operative haemodynamic events., Results: Data from 95 patients were analysed. Intraoperative remifentanil consumption was lower in the PRD-guided group than in the control group: median [IQR], 0.09 [0.07 to 0.11] vs. 0.14 [0.12 to 0.16] μg kg-1 min-1, with a mean difference (95% confidence Interval, CI) of 0.048 (0.035 to 0.060) μg kg-1 min-1; P < 0.0001. Morphine consumption was 0.13 [0.1 to 0.5] vs. 0.15 [0.11 to 0.4] mg kg-1 (P = 0.52) in the PRD-guided and control groups, respectively. The number of hypertensive and tachycardia events was greater in the PRD-guided group than in the control group: Hypertensive events 60.4% vs. 32.6%, relative risk 1.85 (95% CI, 1.24 to 2.84), P = 0.004; tachycardia events 31.6% vs. 4.3%, relative risk 2.09 (95% CI, 1.45 to 2.84), P < 0.001., Conclusions: When PRD is used to differentiate between haemodynamic events arising from noxious stimuli and those events because of other nonsurgical stimuli, then intra-operative remifentanil administration is reduced intra-operatively during laparoscopic surgery but there was no change in postoperative morphine consumption., Trial Registration: Clinicaltrials.gov NCT02116868., (Copyright © 2021 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.)
- Published
- 2021
- Full Text
- View/download PDF
24. LSP5-2157 a new inhibitor of vesicular glutamate transporters.
- Author
-
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse FC, Brabet I, Laras Y, Bertrand HO, Acher F, Pin JP, Puel JL, Giros B, Epelbaum J, Rosenmund C, Dutar P, Daumas S, El Mestikawy S, and Pietrancosta N
- Subjects
- Action Potentials drug effects, Animals, Cochlea drug effects, Cochlear Nerve drug effects, Excitatory Postsynaptic Potentials drug effects, Guinea Pigs, Hippocampus cytology, Hippocampus drug effects, Mice, Mice, Inbred C57BL, Models, Molecular, Neurons drug effects, Synapses drug effects, Synaptic Transmission drug effects, Vesicular Glutamate Transport Proteins metabolism, Vesicular Glutamate Transport Proteins antagonists & inhibitors
- Abstract
Vesicular glutamate transporters (VGLUT1-3) mediate the uptake of glutamate into synaptic vesicles. VGLUTs are pivotal actors of excitatory transmission and of almost all brain functions. Their implication in various pathologies has been clearly documented. Despite their functional importance, the pharmacology of VGLUTs is limited to a few dyes such as Trypan Blue, Rose Bengal or Brilliant Yellow type. Here, we report the design and evaluation of new potent analogs based on Trypan Blue scaffold. Our best compound, named LSP5-2157, has an EC50 of 50 nM on glutamate vesicular uptake. Using a 3D homology model of VGLUT1 and docking experiments, we determined its putative binding subdomains within vesicular glutamate transporters and validated the structural requirement for VGLUT inhibition. To better estimate the specificity and potency of LSP5-2157, we also investigated its ability to block glutamatergic transmission in autaptic hippocampal cells. Neither glutamate receptors nor GABAergic transmission or transmission machinery were affected by LSP5-2157. Low doses of compound reversibly reduce glutamatergic neurotransmission in hippocampal autpases. LSP5-2157 had a low and depressing effect on synaptic efficacy in hippocampal slice. Furthermore, LSP5-2157 had no effect on NMDA-R- mediated fEPSP but reduce synaptic plasticity induced by 3 trains of 100 Hz. Finally, LSP5-2157 had the capacity to inhibit VGLUT3-dependent auditory synaptic transmission in the guinea pig cochlea. In this model, it abolished the compound action potential of auditory nerve at high concentration showing the limited permeation of LSP5-2157 in an in-vivo model. In summary, the new ligand LSP5-2157, has a high affinity and specificity for VGLUTs and shows some permeability in isolated neuron, tissue preparations or in vivo in the auditory system. These findings broaden the field of VGLUTs inhibitors and open the way to their use to assess glutamatergic functions in vitro and in vivo., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Differential expression of VGLUT3 in laboratory mouse strains: Impact on drug-induced hyperlocomotion and anxiety-related behaviors.
- Author
-
Sakae DY, Ramet L, Henrion A, Poirel O, Jamain S, El Mestikawy S, and Daumas S
- Subjects
- Amino Acid Transport Systems, Acidic metabolism, Animals, Anxiety chemically induced, Brain drug effects, Brain metabolism, Brain physiopathology, Cocaine toxicity, Hyperkinesis chemically induced, Locomotion, Male, Maze Learning, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred DBA, Amino Acid Transport Systems, Acidic genetics, Anxiety genetics, Cocaine-Related Disorders genetics, Hyperkinesis genetics
- Abstract
The atypical vesicular glutamate transporter VGLUT3 is present in subpopulations of GABAergic interneurons in the cortex and the hippocampus, in subgroups of serotoninergic neurons in raphe nuclei, and in cholinergic interneurons in the striatum. C56BL/6N mice that no longer express VGLUT3 (VGLUT3
-/- ) display anxiety-associated phenotype, increased spontaneous and cocaine-induced locomotor activity and decreased haloperidol-induced catalepsy. Inbred mouse strains differ markedly in their sensitivity to anxiety and behavioral responses elicited by drugs. The purpose of this study was to investigate strain differences in VGLUT3 expression levels and its potential correlates with anxiety and reward-guided behaviors. Five inbred mouse lines were chosen according to their contrasted anxiety and drugs sensitivity: C57BL/6N, C3H/HeN, DBA/2J, 129/Sv, and BALB/c. VGLUT3 protein expression was measured in different brain areas involved in reward or mood regulation (such as the striatum, the hippocampus, and raphe nuclei) and genetic variations in Slc17a8, the gene encoding for VGLUT3, have been explored. These five inbred mouse strains express very different levels of VGLUT3, which cannot be attributed to the genetic variation of the Slc17a8 locus. Furthermore, mice behavior in the open field, elevated plus maze, spontaneous- and cocaine-induced locomotor was highly heterogeneous and only partially correlated to VGLUT3 levels. These data highlight the fact that one single gene polymorphism could not account for VGLUT3 expression variations, and that region specific VGLUT3 expression level variations might play a key role in the modulation of discrete behaviors., (© 2018 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.)- Published
- 2019
- Full Text
- View/download PDF
26. Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages.
- Author
-
Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, Katsel P, Mechawar N, Haroutunian V, Epelbaum J, Daumas S, and El Mestikawy S
- Subjects
- Aged, 80 and over, Choline O-Acetyltransferase metabolism, Female, Glutamic Acid metabolism, Humans, Male, Neurons metabolism, Synaptophysin metabolism, Vesicular Glutamate Transport Protein 1 metabolism, Vesicular Inhibitory Amino Acid Transport Proteins metabolism, Alzheimer Disease metabolism, Biomarkers metabolism, Cognition physiology, Prefrontal Cortex metabolism, Synapses metabolism
- Abstract
Synaptic loss, plaques and neurofibrillary tangles are viewed as hallmarks of Alzheimer's disease (AD). This study investigated synaptic markers in neocortical Brodmann area 9 (BA9) samples from 171 subjects with and without AD at different levels of cognitive impairment. The expression levels of vesicular glutamate transporters (VGLUT1&2), glutamate uptake site (EAAT2), post-synaptic density protein of 95 kD (PSD95), vesicular GABA/glycine transporter (VIAAT), somatostatin (som), synaptophysin and choline acetyl transferase (ChAT) were evaluated. VGLUT2 and EAAT2 were unaffected by dementia. The VGLUT1, PSD95, VIAAT, som, ChAT and synaptophysin expression levels significantly decreased as dementia progressed. The maximal decrease varied between 12% (synaptophysin) and 42% (som). VGLUT1 was more strongly correlated with dementia than all of the other markers (polyserial correlation = -0.41). Principal component analysis using these markers was unable to differentiate the CDR groups from one another. Therefore, the status of the major synaptic markers in BA9 does not seem to be linked to the cognitive status of AD patients. The findings of this study suggest that the loss of synaptic markers in BA9 is a late event that is only weakly related to AD dementia.
- Published
- 2018
- Full Text
- View/download PDF
27. Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles.
- Author
-
Ramet L, Zimmermann J, Bersot T, Poirel O, De Gois S, Silm K, Sakae DY, Mansouri-Guilani N, Bourque MJ, Trudeau LE, Pietrancosta N, Daumas S, Bernard V, Rosenmund C, and El Mestikawy S
- Subjects
- Amino Acid Sequence, Animals, Animals, Newborn, Cells, Cultured, Female, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Random Allocation, Brain metabolism, Point Mutation physiology, Synaptic Vesicles genetics, Synaptic Vesicles metabolism, Vesicular Glutamate Transport Proteins genetics, Vesicular Glutamate Transport Proteins metabolism
- Abstract
The atypical vesicular glutamate transporter type 3 (VGLUT3) is expressed by subpopulations of neurons using acetylcholine, GABA, or serotonin as neurotransmitters. In addition, VGLUT3 is expressed in the inner hair cells of the auditory system. A mutation (p.A211V) in the gene that encodes VGLUT3 is responsible for progressive deafness in two unrelated families. In this study, we investigated the consequences of the p.A211V mutation in cell cultures and in the CNS of a mutant mouse. The mutation substantially decreased VGLUT3 expression (-70%). We measured VGLUT3-p.A211V activity by vesicular uptake in BON cells, electrophysiological recording of isolated neurons, and its ability to stimulate serotonergic accumulation in cortical synaptic vesicles. Despite a marked loss of expression, the activity of the mutated isoform was only minimally altered. Furthermore, mutant mice displayed none of the behavioral alterations that have previously been reported in VGLUT3 knock-out mice. Finally, we used stimulated emission depletion microscopy to analyze how the mutation altered VGLUT3 distribution within the terminals of mice expressing the mutated isoform. The mutation appeared to reduce the expression of the VGLUT3 transporter by simultaneously decreasing the number of VGLUT3-positive synaptic vesicles and the amount of VGLUT3 per synapses. These observations suggested that VGLUT3 global activity is not linearly correlated with VGLUT3 expression. Furthermore, our data unraveled a nonuniform distribution of VGLUT3 in synaptic vesicles. Identifying the mechanisms responsible for this complex vesicular sorting will be critical to understand VGLUT's involvement in normal and pathological conditions. SIGNIFICANCE STATEMENT VGLUT3 is an atypical member of the vesicular glutamate transporter family. A point mutation of VGLUT3 (VGLUT3-p.A211V) responsible for a progressive loss of hearing has been identified in humans. We observed that this mutation dramatically reduces VGLUT3 expression in terminals (∼70%) without altering its function. Furthermore, using stimulated emission depletion microscopy, we found that reducing the expression levels of VGLUT3 diminished the number of VGLUT3-positive vesicles at synapses. These unexpected findings challenge the vision of a uniform distribution of synaptic vesicles at synapses. Therefore, the overall activity of VGLUT3 is not proportional to the level of VGLUT3 expression. These data will be key in interpreting the role of VGLUTs in human pathologies., (Copyright © 2017 the authors 0270-6474/17/374182-19$15.00/0.)
- Published
- 2017
- Full Text
- View/download PDF
28. Erratum to: Glutamate receptors of the delta family are widely expressed in the adult brain.
- Author
-
Hepp R, Hay YA, Aguado C, Lujan R, Dauphinot L, Potier MC, Nomura S, Poirel O, El Mestikawy S, Lambolez B, and Tricoire L
- Published
- 2015
- Full Text
- View/download PDF
29. Glutamate receptors of the delta family are widely expressed in the adult brain.
- Author
-
Hepp R, Hay YA, Aguado C, Lujan R, Dauphinot L, Potier MC, Nomura S, Poirel O, El Mestikawy S, Lambolez B, and Tricoire L
- Subjects
- Animals, Gene Expression physiology, Mice, Aging physiology, Cerebellum metabolism, Hippocampus metabolism, Neurons metabolism, Receptors, Glutamate metabolism, Synapses metabolism
- Abstract
Recent reports point to critical roles of glutamate receptor subunit delta2 (GluD2) at excitatory synapses and link GluD1 gene alteration to schizophrenia but the expression patterns of these subunits in the brain remain almost uncharacterized. We examined the distribution of GluD1-2 mRNAs and proteins in the adult rodent brain, focusing mainly on GluD1. In situ hybridization revealed widespread neuronal expression of the GluD1 mRNA, with higher levels occurring in several forebrain regions and lower levels in cerebellum. Quantitative RT-PCR assessed differential GluD1 expression in cortex and cerebellum, and revealed GluD2 expression in cortex, albeit at markedly lower level than in cerebellum. Likewise, a high GluD1/GluD2 mRNA ratio was observed in cortex and a low ratio in cerebellum. GluD1 and GluD2 mRNAs were co-expressed in single cortical and hippocampal neurons, with a large predominance of GluD1. Western blots using GluD1- and GluD2-specific antibodies showed expression of both subunits in various brain structures, but not in non-nervous tissues examined. Both delta subunits were upregulated during postnatal development. Widespread neuronal expression of the GluD1 protein was confirmed using immunohistochemistry. Examination at the electron microscopic level in the hippocampus revealed that GluD1 was mainly localized at postsynaptic density of excitatory synapses on pyramidal cells. Control experiments performed using mice carrying deletion of the GluD1- or the GluD2-encoding gene confirmed the specificity of the present mRNA and protein analyses. Our results support a role for the delta family of glutamate receptors at excitatory synapses in neuronal networks throughout the adult brain.
- Published
- 2015
- Full Text
- View/download PDF
30. Distribution of vesicular glutamate transporters in the human brain.
- Author
-
Vigneault É, Poirel O, Riad M, Prud'homme J, Dumas S, Turecki G, Fasano C, Mechawar N, and El Mestikawy S
- Abstract
Glutamate is the major excitatory transmitter in the brain. Vesicular glutamate transporters (VGLUT1-3) are responsible for uploading glutamate into synaptic vesicles. VGLUT1 and VGLUT2 are considered as specific markers of canonical glutamatergic neurons, while VGLUT3 is found in neurons previously shown to use other neurotransmitters than glutamate. Although there exists a rich literature on the localization of these glutamatergic markers in the rodent brain, little is currently known about the distribution of VGLUT1-3 in the human brain. In the present study, using subtype specific probes and antisera, we examined the localization of the three vesicular glutamate transporters in the human brain by in situ hybridization, immunoautoradiography and immunohistochemistry. We found that the VGLUT1 transcript was highly expressed in the cerebral cortex, hippocampus and cerebellum, whereas VGLUT2 mRNA was mainly found in the thalamus and brainstem. VGLUT3 mRNA was localized in scarce neurons within the cerebral cortex, hippocampus, striatum and raphe nuclei. Following immunoautoradiographic labeling, intense VGLUT1- and VGLUT2-immunoreactivities were observed in all regions investigated (cerebral cortex, hippocampus, caudate-putamen, cerebellum, thalamus, amygdala, substantia nigra, raphe) while VGLUT3 was absent from the thalamus and cerebellum. This extensive mapping of VGLUT1-3 in human brain reveals distributions that correspond for the most part to those previously described in rodent brains.
- Published
- 2015
- Full Text
- View/download PDF
31. Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.
- Author
-
Favre-Besse FC, Poirel O, Bersot T, Kim-Grellier E, Daumas S, El Mestikawy S, Acher FC, and Pietrancosta N
- Subjects
- Animals, Azo Compounds chemical synthesis, Azo Compounds chemistry, Coloring Agents chemical synthesis, Coloring Agents chemistry, Dose-Response Relationship, Drug, Molecular Structure, Rats, Structure-Activity Relationship, Azo Compounds pharmacology, Coloring Agents pharmacology, Drug Design, Vesicular Glutamate Transport Proteins antagonists & inhibitors
- Abstract
Vesicular Glutamate Transporters (VGLUTs) allow the loading of presynapic glutamate vesicles and thus play a critical role in glutamatergic synaptic transmission. VGLUTs have proved to be involved in several major neuropathologies and directly correlated to clinical dementia in Alzheimer and Parkinson's disease. Accordingly VGLUT represent a key biological target or biomarker for neuropathology treatment or diagnostic. Yet, despite the pivotal role of VGLUTs, their pharmacology appears quite limited. Known competitive inhibitors are restricted to some dyes as Trypan Blue (TB) and glutamate mimics. This lack of pharmacological tools has heavily hampered VGLUT investigations. Here we report a rapid access to small molecules that combine benefits of TB and dicarboxylic quinolines (DCQs). Their ability to block vesicular glutamate uptake was evaluated. Several compounds displayed low micromolar inhibitory potency when size related compounds are thirty to forty times less potent (i.e. DCQ). We then confirmed the VGLUT selectivity by measuring the effect of the series on vesicular monoamine transport and on metabotropic glutamate receptor activity. These inhibitors are synthesized in only two steps and count among the best pharmacological tools for VGLUTs studies., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
32. The vesicular glutamate transporter VGLUT3 contributes to protection against neonatal hypoxic stress.
- Author
-
Miot S, Voituron N, Sterlin A, Vigneault E, Morel L, Matrot B, Ramanantsoa N, Amilhon B, Poirel O, Lepicard E, Mestikawy SE, Hilaire G, and Gallego J
- Subjects
- Animals, Animals, Newborn, Brain Stem anatomy & histology, Brain Stem physiology, Mice, Mice, Transgenic, Respiration, Serotonin physiology, Stress, Physiological, Amino Acid Transport Systems, Acidic physiology, Hypoxia physiopathology
- Abstract
Neonates respond to hypoxia initially by increasing ventilation, and then by markedly decreasing both ventilation (hypoxic ventilatory decline) and oxygen consumption (hypoxic hypometabolism). This latter process, which vanishes with age, reflects a tight coupling between ventilatory and thermogenic responses to hypoxia. The neurological substrate of hypoxic hypometabolism is unclear, but it is known to be centrally mediated, with a strong involvement of the 5-hydroxytryptamine (5-HT, serotonin) system. To clarify this issue, we investigated the possible role of VGLUT3, the third subtype of vesicular glutamate transporter. VGLUT3 contributes to glutamate signalling by 5-HT neurons, facilitates 5-HT transmission and is expressed in strategic regions for respiratory and thermogenic control. We therefore assumed that VGLUT3 might significantly contribute to the response to hypoxia. To test this possibility, we analysed this response in newborn mice lacking VGLUT3 using anatomical, biochemical, electrophysiological and integrative physiology approaches. We found that the lack of VGLUT3 did not affect the histological organization of brainstem respiratory networks or respiratory activity under basal conditions. However, it impaired respiratory responses to 5-HT and anoxia, showing a marked alteration of central respiratory control. These impairments were associated with altered 5-HT turnover at the brainstem level. Furthermore, under cold conditions, the lack of VGLUT3 disrupted the metabolic rate, body temperature, baseline breathing and the ventilatory response to hypoxia. We conclude that VGLUT3 expression is dispensable under basal conditions but is required for optimal response to hypoxic stress in neonates.
- Published
- 2012
- Full Text
- View/download PDF
33. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety.
- Author
-
Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, and El Mestikawy S
- Subjects
- Amino Acid Transport Systems, Acidic genetics, Animals, Anxiety metabolism, Autoreceptors physiology, Cerebral Cortex physiopathology, Hippocampus physiopathology, Mice, Mice, Knockout, Presynaptic Terminals metabolism, Raphe Nuclei physiopathology, Receptor, Serotonin, 5-HT1A physiology, Serotonin Plasma Membrane Transport Proteins metabolism, Synaptic Transmission, Vesicular Monoamine Transport Proteins metabolism, Amino Acid Transport Systems, Acidic physiology, Anxiety physiopathology, Serotonin physiology
- Abstract
Three different subtypes of H(+)-dependent carriers (named VGLUT1-3) concentrate glutamate into synaptic vesicles before its exocytotic release. Neurons using other neurotransmitter than glutamate (such as cholinergic striatal interneurons and 5-HT neurons) express VGLUT3. It was recently reported that VGLUT3 increases acetylcholine vesicular filling, thereby, stimulating cholinergic transmission. This new regulatory mechanism is herein designated as vesicular-filling synergy (or vesicular synergy). In the present report, we found that deletion of VGLUT3 increased several anxiety-related behaviors in adult and in newborn mice as early as 8 d after birth. This precocious involvement of a vesicular glutamate transporter in anxiety led us to examine the underlying functional implications of VGLUT3 in 5-HT neurons. On one hand, VGLUT3 deletion caused a significant decrease of 5-HT(1A)-mediated neurotransmission in raphe nuclei. On the other hand, VGLUT3 positively modulated 5-HT transmission of a specific subset of 5-HT terminals from the hippocampus and the cerebral cortex. VGLUT3- and VMAT2-positive serotonergic fibers show little or no 5-HT reuptake transporter. These results unravel the existence of a novel subset of 5-HT terminals in limbic areas that might play a crucial role in anxiety-like behaviors. In summary, VGLUT3 accelerates 5-HT transmission at the level of specific 5-HT terminals and can exert an inhibitory control at the raphe level. Furthermore, our results suggest that the loss of VGLUT3 expression leads to anxiety-associated behaviors and should be considered as a potential new target for the treatment of this disorder.
- Published
- 2010
- Full Text
- View/download PDF
34. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
- Author
-
Kashani A, Lepicard E, Poirel O, Videau C, David JP, Fallet-Bianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, and El Mestikawy S
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease complications, Cognition Disorders complications, Female, Humans, Male, Middle Aged, Statistics as Topic, Alzheimer Disease metabolism, Cognition Disorders metabolism, Prefrontal Cortex metabolism, Vesicular Glutamate Transport Protein 1 metabolism, Vesicular Glutamate Transport Protein 2 metabolism
- Abstract
Several lines of evidence suggest that the glutamatergic system is severely impaired in Alzheimer disease (AD). Here, we assessed the status of glutamatergic terminals in AD using the first available specific markers, the vesicular glutamate transporters VGLUT1 and VGLUT2. We quantified VGLUT1 and VGLUT2 in the prefrontal dorsolateral cortex (Brodmann area 9) of controls and AD patients using specific antiserums. A dramatic decrease in VGLUT1 and VGLUT2 was observed in AD using Western blot. Similar decreases were observed in an independent group of subjects using immunoautoradiography. The VGLUT1 reduction was highly correlated with the degree of cognitive impairment, assessed with the clinical dementia rating (CDR) score. A significant albeit weaker correlation was also observed with VGLUT2. These findings provide evidence indicating that glutamatergic systems are severely impaired in the A9 region of AD patients and that this impairment is strongly correlated with the progression of cognitive decline. Our results suggest that VGLUT1 expression in the prefrontal cortex could be used as a valuable neurochemical marker of dementia in AD.
- Published
- 2008
- Full Text
- View/download PDF
35. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone.
- Author
-
Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier J, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, Hanoun N, Saurini F, Kemel ML, Gasnier B, Giros B, and El Mestikawy S
- Subjects
- Acetylcholine biosynthesis, Amino Acid Transport Systems, Acidic genetics, Animals, Antipsychotic Agents pharmacology, Dopamine Uptake Inhibitors pharmacology, Down-Regulation genetics, Drug Resistance genetics, Interneurons metabolism, Mice, Mice, Knockout, Motor Activity genetics, Organ Culture Techniques, Presynaptic Terminals drug effects, Rats, Synaptic Transmission drug effects, Synaptic Vesicles metabolism, Vesicular Acetylcholine Transport Proteins metabolism, Acetylcholine metabolism, Amino Acid Transport Systems, Acidic metabolism, Corpus Striatum metabolism, Glutamic Acid metabolism, Presynaptic Terminals metabolism, Synaptic Transmission genetics
- Abstract
Three subtypes of vesicular transporters accumulate glutamate into synaptic vesicles to promote its vesicular release. One of the subtypes, VGLUT3, is expressed in neurons, including cholinergic striatal interneurons, that are known to release other classical transmitters. Here we showed that disruption of the Slc17a8 gene (also known as Vglut3) caused an unexpected hypocholinergic striatal phenotype. Vglut3(-/-) mice were more responsive to cocaine and less prone to haloperidol-induced catalepsy than wild-type littermates, and acetylcholine release was decreased in striatum slices lacking VGLUT3. These phenotypes were associated with a colocalization of VGLUT3 and the vesicular acetylcholine transporter (VAChT) in striatal synaptic vesicles and the loss of a synergistic effect of glutamate on vesicular acetylcholine uptake. We propose that this vesicular synergy between two transmitters is the result of the unbalanced bioenergetics of VAChT, which requires anion co-entry for continuing vesicular filling. Our study reveals a previously unknown effect of glutamate on cholinergic synapses with potential functional and pharmacological implications.
- Published
- 2008
- Full Text
- View/download PDF
36. Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice.
- Author
-
Robin MA, Demeilliers C, Sutton A, Paradis V, Maisonneuve C, Dubois S, Poirel O, Lettéron P, Pessayre D, and Fromenty B
- Subjects
- Animals, Caspase 3, Caspases metabolism, DNA, Mitochondrial analysis, Ethanol blood, Glutathione metabolism, In Situ Nick-End Labeling, Lipid Peroxidation, Liver metabolism, Liver pathology, Male, Mice, Mice, Inbred C57BL, Mice, Obese, Mitochondria metabolism, Obesity metabolism, Oxidative Stress, Superoxide Dismutase metabolism, Apoptosis drug effects, Ethanol toxicity, Liver drug effects, NF-kappa B metabolism, Obesity pathology, Tumor Necrosis Factor-alpha biosynthesis
- Abstract
Both obesity and alcohol can cause oxidative stress, cytokine induction, and steatohepatitis. To determine the consequences of their combination, we compared the hepatic effects of moderate ethanol binges in lean and obese ob/ob mice. Mice received water or ethanol (2.5 g/kg) by gastric intubation daily for 4 days, and were killed 2 hours after the last administration. Some obese mice also received pentoxifylline, an inhibitor of tumor necrosis factor-alpha (TNF-alpha) production, before each ethanol administration. In lean mice, these moderate ethanol doses did not increase plasma TNF-alpha and hepatic caspase-3 activity, but triggered some apoptotic hepatocytes. Naive ob/ob mice had a few necrotic and apoptotic hepatocytes, but exhibited little oxidative stress, possibly because of adaptive increases in manganese superoxide dismutase, heat shock protein 70 (Hsp70), mitochondrial cytochrome c, and mitochondrial DNA. Alcohol administration to ob/ob mice did not increase oxidative stress despite increased CYP2E1, but increased plasma TNF-alpha, further increased Hsp70, and profoundly decreased p65 nuclear factor kappaB (NF-kappaB) protein and DNA-binding activity in nuclear extracts. Caspase-3 was activated, and more apoptotic hepatocytes were found in intoxicated obese mice than naive obese mice. In intoxicated obese mice, pentoxifylline fully prevented the increase in plasma TNF-alpha the decrease in nuclear NF-kappaB activity, and the increase in hepatic caspase-3, and it also decreased hepatic triglycerides. In conclusion, obese mice develop adaptations that may limit oxidative stress. Moderate ethanol intoxication does not increase oxidative stress in obese mice, but increases TNF-alpha and also decreases nuclear NF-kappaB activity, thus unleashing the apoptotic effects of TNF-alpha.
- Published
- 2005
- Full Text
- View/download PDF
37. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling.
- Author
-
Tazi KA, Moreau R, Hervé P, Dauvergne A, Cazals-Hatem D, Bert F, Poirel O, Rabiller A, and Lebrec D
- Subjects
- Animals, Aorta enzymology, Aorta immunology, Bacterial Translocation drug effects, Feces microbiology, Liver Cirrhosis immunology, Liver Cirrhosis pathology, Male, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III, Phosphorylation, Protein Serine-Threonine Kinases metabolism, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-akt, Rats, Rats, Sprague-Dawley, Signal Transduction drug effects, Signal Transduction physiology, Transaminases blood, Tumor Necrosis Factor-alpha immunology, Tumor Necrosis Factor-alpha metabolism, Up-Regulation drug effects, Aorta drug effects, Enzyme Inhibitors pharmacology, Liver Cirrhosis metabolism, Nitric Oxide Synthase metabolism, Norfloxacin pharmacology
- Abstract
Background & Aims: Arterial vasodilation plays a role in the pathogenesis of the complications of cirrhosis. This vasodilation is caused by the overproduction of arterial nitric oxide (NO). Bacterial translocation may be involved in NO synthase (NOS) up-regulation by activating both endothelial NOS (eNOS) and inducible NOS (iNOS). The prevention of intestinal gram-negative translocation by norfloxacin administration corrects systemic circulatory changes by decreasing NO production in cirrhosis. However, the signaling mechanisms for NO overproduction from bacterial translocation are unknown. In this study, we investigated the signal transduction pathway of bacterial translocation-induced aortic NOS up-regulation in cirrhotic rats., Methods: Proinflammatory cytokine levels, Akt and NOS activities, eNOS phosphorylation, and NOS expressions were assessed in aorta from norfloxacin-treated and untreated cirrhotic rats. Norfloxacin was administered to reduce intestinal bacterial translocation., Results: Aortic eNOS and iNOS protein expressions, Akt activity, and eNOS phosphorylation by Akt at serine 1177 were up-regulated in cirrhotic rats. Norfloxacin administration significantly decreased the incidence of gram-negative translocation and proinflammatory cytokine (tumor necrosis factor-alpha, interferon-gamma, and interleukin-6) levels; norfloxacin also decreased aortic Akt activity, eNOS phosphorylation, and NOS expressions and activities. The decrease in aortic Akt activity and NOS expressions also was obtained after colistin or anti-tumor necrosis factor-alpha antibody administration to cirrhotic rats., Conclusions: This study identifies a signaling pathway in which bacterial translocation induces aortic NOS up-regulation and thus NO overproduction in cirrhotic rats. These results strongly suggest that bacterial translocation and proinflammatory cytokines play a role in systemic NO overproduction in cirrhosis by the Akt pathway.
- Published
- 2005
- Full Text
- View/download PDF
38. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
- Author
-
Ahloulay M, Bankir L, Lugnier C, Le Bec A, Poirel O, Moreau R, and Lebrec D
- Subjects
- Analysis of Variance, Animals, Ascites pathology, Cyclic AMP metabolism, Disease Models, Animal, Glomerular Filtration Rate drug effects, Infusions, Intravenous, Kidney Function Tests, Liver Cirrhosis, Experimental pathology, Male, Probability, Random Allocation, Rats, Rats, Sprague-Dawley, Reference Values, Sensitivity and Specificity, Ascites drug therapy, Liver Cirrhosis, Experimental drug therapy, Phosphodiesterase Inhibitors pharmacology, Rolipram pharmacology
- Abstract
Background: The mechanisms responsible for renal dysfunction and sodium retention in cirrhosis remain unclear. Cyclic AMP (cAMP) regulates sodium reabsorption in the proximal nephron. This study investigates the role of cAMP metabolism in renal dysfunction in cirrhosis., Methods: Renal function was studied by the clearance technique in anesthetized control and cirrhotic rats with or without ascites. cAMP phosphodiesterase (PDE) activity was measured in the renal cortex in vitro. Moroever, the effects on renal function of the intravenous administration of cAMP and rolipram, a powerful and specific cAMP-PDE4 inhibitor, were evaluated., Results: In control and in non-ascitic cirrhotic rats, cAMP administration significantly increased sodium and phosphate excretions, but did not change these excretions in cirrhotic rats with ascites. cAMP-PDE activity was higher in ascitic than in control rats (P < 0.05). Rolipram infusion significantly increased sodium and phosphate excretion only in cirrhotic rats with ascites., Conclusion: These results suggest that increased renal cAMP-PDE activity is responsible for resistance to the natriuretic effects of cAMP in cirrhosis and plays a role in the development of ascites., (Copyright Blackwell Munksgaard 2005)
- Published
- 2005
- Full Text
- View/download PDF
39. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
- Author
-
Moreau R, Barrière E, Tazi KA, Lardeux B, Dargère D, Urbanowicz W, Poirel O, Chauvelot-Moachon L, Guimont MC, Bernuau D, and Lebrec D
- Subjects
- Alanine Transaminase blood, Animals, Aorta, Thoracic enzymology, Blood Pressure drug effects, Enzyme Inhibitors pharmacology, Gene Expression Regulation, Enzymologic drug effects, Hypotension chemically induced, Hypotension drug therapy, Hypotension metabolism, Lipopolysaccharides, Liver Cirrhosis, Biliary drug therapy, Lysine pharmacology, Male, Nitric Oxide Synthase antagonists & inhibitors, Nitric Oxide Synthase genetics, Nitric Oxide Synthase Type II, Phenylephrine pharmacology, RNA, Messenger analysis, Rats, Rats, Sprague-Dawley, Shock, Septic chemically induced, Shock, Septic metabolism, Terlipressin, Tumor Necrosis Factor-alpha metabolism, Liver Cirrhosis, Biliary metabolism, Lypressin analogs & derivatives, Lypressin pharmacology, Lysine analogs & derivatives, Nitric Oxide Synthase metabolism, Shock, Septic drug therapy, Vasoconstrictor Agents pharmacology
- Abstract
In cirrhosis, lipopolysaccharide (LPS, a product of Gram-negative bacteria) in the blood may cause septic shock. LPS-elicited induction of arterial inducible nitric oxide synthase (iNOS) results in nitric oxide (NO)-induced vasodilation, which causes arterial hypotension and hyporeactivity to alpha(1)-adrenergic constrictors. In vitro studies have suggested that vasopressin inhibits iNOS expression in cultured vascular smooth muscle cells exposed to LPS. Thus, the aim of this study was to investigate the effects of terlipressin administration (a vasopressin analog) on in vivo LPS-induced aortic iNOS in rats with cirrhosis. LPS (1 mg/kg, intravenously) was administered followed by the intravenous administration of terlipressin (0.05 mg/kg, intravenously) or placebo 1 hour later. Arterial pressure was measured, and contractions to phenylephrine (an alpha(1)-adrenoceptor agonist), iNOS activity, and iNOS expressions (mRNA and protein) were investigated in isolated aortas. LPS-induced arterial hypotension and aortic hyporeactivity to phenylephrine were abolished in rats that received terlipressin. LPS-induced aortic iNOS activity and expression were suppressed in terlipressin-treated rats. In conclusion, in LPS-challenged rats with cirrhosis, terlipressin administration inhibits in vivo LPS-induced aortic iNOS expression. Terlipressin administration may be a novel approach for the treatment of arterial hypotension and hyporeactivity to alpha(1)-adrenergic constrictors in patients with cirrhosis and septic shock.
- Published
- 2002
- Full Text
- View/download PDF
40. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis.
- Author
-
Tazi KA, Barrière E, Moreau R, Heller J, Sogni P, Pateron D, Poirel O, and Lebrec D
- Subjects
- Animals, Aorta metabolism, Constriction, Pathologic, Endothelial Growth Factors metabolism, Endothelial Growth Factors pharmacology, HSP90 Heat-Shock Proteins metabolism, Lymphokines metabolism, Lymphokines pharmacology, Male, Nitric Oxide Synthase Type III, Portal Vein enzymology, Rats, Rats, Sprague-Dawley, Reference Values, Stress, Mechanical, Up-Regulation, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Aorta enzymology, Liver Cirrhosis, Biliary enzymology, Nitric Oxide Synthase metabolism
- Abstract
Background & Aims: In rats with portal vein stenosis, the initial cause of aortic nitric oxide (NO) overproduction might be overactivation of endothelial NO synthase (eNOS) related to increased shear stress. Cardiac output is higher in cirrhosis than in extrahepatic portal hypertension. The aims of this study were to evaluate the role of shear stress, vascular endothelial growth factor (VEGF), and cytokines in aortic eNOS up-regulation in rats with biliary cirrhosis and to compare these results with those in rats with portal vein stenosis., Methods: NOS activities, NOS protein, heat shock protein (Hsp) 90, and VEGF expressions were studied in rat aortas. Propranolol was administered to rats with cirrhosis to reduce cardiac output and thus shear stress., Results: In cirrhotic rats, the aortic eNOS protein was 3.0 and 1.7 times higher than in control and portal vein-stenosed rats, respectively. In cirrhotic rats, the Hsp90 content was 3.2 and 2.2 times higher than in control and portal vein-stenosed rats, respectively. Propranolol decreased NOS activity by 47% and eNOS and Hsp90 expression by 75% and 72%, respectively. Aortic VEGF expression was decreased in cirrhotic rats. VEGF-induced stimulation of NOS activity was greater in aortas from control rats than in aortas from portal vein-stenosed or cirrhotic rat aortas. eNOS expression was up-regulated after VEGF incubation. After lipopolysaccharide administration, eNOS expression did not change in portal vein-stenosed or cirrhotic rats., Conclusions: This study shows that in aortas from rats with biliary cirrhosis, systemic vasodilation depends mainly on eNOS up-regulation related to shear stress.
- Published
- 2002
- Full Text
- View/download PDF
41. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
- Author
-
Pateron D, Tazi KA, Sogni P, Heller J, Chagneau C, Poirel O, Philippe M, Moreau R, and Lebrec D
- Subjects
- Adrenergic beta-Antagonists pharmacology, Animals, Antihypertensive Agents pharmacology, Atenolol pharmacology, Constriction, Pathologic, In Vitro Techniques, Male, Nitric Oxide Synthase genetics, Nitric Oxide Synthase Type III, Portal Vein physiopathology, Propranolol pharmacology, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Reference Values, Vasodilator Agents pharmacology, Aorta enzymology, Hypertension, Portal physiopathology, Nitric Oxide Synthase physiology, Vasodilation physiology
- Abstract
Background & Aims: In portal hypertension, the mechanisms responsible for nitric oxide (NO) overproduction and vasodilation have not yet been clearly identified. One hypothesis is that NO synthase (NOS) 3 is overactivated because of shear stress in endothelial cells caused by hyperkinetic circulation. The aim of this study was to evaluate aortic NOS3 after a reduction of blood flow by long-time beta-adrenoceptor antagonist administration., Methods: Propranolol or atenolol was administered by gavage in portal vein-stenosed and sham-operated rats. The vascular reactivity of thoracic aortic rings to phenylephrine, total aortic NOS activity, and aortic NOS3 messenger RNA and protein expressions were studied., Results: After propranolol or atenolol administration, the aortic hyporesponse returned to normal in portal vein-stenosed rats. Total aortic NOS activity was higher in portal vein-stenosed aortas and significantly decreased after beta-blocker administration. Aortic NOS3 expressions were more marked in portal vein-stenosed aortas than in controls, but NOS3 expressions were reduced after propranolol administration., Conclusions: In portal hypertension, aortic NOS3 activity and expressions are enhanced but return to normal after beta-blocker administration. These results suggest that in portal hypertension, increased shear stress, related to high blood flow, induces enhanced aortic NOS3.
- Published
- 2000
- Full Text
- View/download PDF
42. Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas.
- Author
-
Tazi KA, Moreau R, Heller J, Poirel O, and Lebrec D
- Subjects
- Animals, Biological Transport drug effects, Down-Regulation, Intracellular Membranes enzymology, Male, Phenylephrine pharmacology, Rats, Rats, Sprague-Dawley, Reference Values, Tetradecanoylphorbol Acetate pharmacology, Time Factors, Tissue Distribution, Vasoconstriction physiology, Vasoconstrictor Agents pharmacology, Aorta physiopathology, Isoenzymes metabolism, Liver Cirrhosis, Experimental physiopathology, Protein Kinase C metabolism, Vasomotor System physiopathology
- Abstract
Background & Aims: Although protein kinase C (PKC) alterations may play a role in the abnormal reactivity of cirrhotic rat aortas, its isoforms and cellular distribution are unknown. We therefore studied the protein expression and cellular distribution of PKC isoforms and their activation in cirrhotic rat aortas., Methods: Endothelium-denuded aortas from control and cirrhotic rats were examined. Immunoblots were performed with PKC isoform-specific antibodies. Aortic reactivity was determined for phorbol myristate acetate and phenylephrine after PKC down-regulation., Results: PKC-alpha expression was reduced in both the cytosolic and membrane fractions in cirrhotic aortas. Trace amounts of PKC-beta were detected in cirrhotic aortas. PKC-delta was detected in the cytosolic fraction of control and cirrhotic aortas. PKC-zeta was detected in the membrane fraction in control aortas and in the cytosolic fraction in cirrhotic aortas. Phorbol myristate acetate and phenylephrine triggered translocation of PKC-alpha and PKC-delta isoforms from the cytosol to the membrane in control aortas; in cirrhotic aortas, only PKC-alpha was translocated. Aortic reactivities were reduced after PKC down-regulation. PKC-alpha and -delta activities were reduced in cirrhotic aortas., Conclusions: These results suggest that a change in PKC isoforms may be responsible in part for the abnormal reactivity and intracellular transduction through the PKC pathway in cirrhotic rat aortas.
- Published
- 2000
- Full Text
- View/download PDF
43. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis.
- Author
-
Pateron D, Oberti F, Lefilliatre P, Veal N, Tazi KA, Sogni P, Poirel O, Heller J, Moreau R, Cales P, and Lebrec D
- Subjects
- Animals, Aorta, Thoracic drug effects, Aorta, Thoracic physiopathology, Carotid Arteries drug effects, Carotid Arteries physiopathology, Culture Techniques, Hemodynamics, Male, Mesenteric Artery, Superior drug effects, Mesenteric Artery, Superior physiopathology, Phenylephrine pharmacology, Rats, Rats, Sprague-Dawley, Regional Blood Flow physiology, Vasoconstriction drug effects, Vasoconstrictor Agents pharmacology, Liver Cirrhosis, Experimental physiopathology, Vasoconstriction physiology
- Abstract
In cirrhosis there is a hyperdynamic circulation, which occurs mainly in the systemic and splanchnic regions. Using isolated-vessel models, previous studies have shown reduced aortic reactivity to vasoconstrictors in rats with cirrhosis. The aim of the present study was to evaluate and compare the vascular responsiveness to phenylephrine in arterial rings and the blood flows from different regions in rats with cirrhosis and controls. Reactivity was studied in isolated thoracic aortic, superior mesenteric arterial and carotid arterial rings from sham-operated and bile-duct-ligated rats by measuring the cumulative concentration-dependent tension induced by phenylephrine (10(-9)-10(-4) M). Blood flows were measured by the radioactive microsphere method. In rats with cirrhosis, a significant hyporeactivity to phenylephrine was observed in both the aorta and the superior mesenteric artery compared with the corresponding arteries of normal rats. This hyporesponsiveness was corrected by N(omega)-nitro-L-arginine (0.1 mM). In contrast, carotid artery reactivity and the responses to N(omega)-nitro-L-arginine were similar in the cirrhotic and control groups. In each case, cardiac output and mesenteric arterial blood flow were significantly higher in cirrhotic than in normal rats. Cerebral blood flows were not significantly different between the two groups. In cirrhotic rats, arterial hyporeactivity may be a consequence of increased regional blood flow and increased production of nitric oxide.
- Published
- 1999
44. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
- Author
-
Heller J, Sogni P, Tazi KA, Chagneau C, Poirel O, Moreau R, and Lebrec D
- Subjects
- Animals, Male, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III, Phenylephrine pharmacology, Portal Vein, Rats, Rats, Sprague-Dawley, Aorta enzymology, Hypertension, Portal enzymology, Lipopolysaccharides pharmacology, Nitric Oxide Synthase metabolism
- Abstract
Hyporeactivity to vasoconstrictors in aortae from portal vein-stenosed rats is associated with an increased activity of endothelial NO synthase (NOS3). In contrast, during sepsis, which is common in cirrhosis, vascular hyporeactivity is associated with an induction of inducible NOS2. The aim of this study was to investigate the in vitro reactivity to phenylephrine and the regulation of NOS2 and NOS3 in aortae from portal vein-stenosed rats after lipopolysaccharide (LPS) administration. Aortic vascular reactivity for phenylephrine, aortic NOS activity, and NOS2 and NOS3 protein expression were determined 5 hours after intravenous LPS or saline administration. Moreover, aortic NOS activity was measured after 5-hour in vitro incubation in LPS. LPS induced a significantly smaller decrease in aortic tension in portal vein-stenosed than in sham-operated rats. Under baseline conditions, aortic NOS activity and NOS3 protein expression were higher in portal vein-stenosed than in sham-operated rats, and NOS2 protein expression was not detected in aortae from either group. After LPS administration, NOS activity and NOS2 protein expression increased significantly less in portal vein-stenosed than in sham-operated rat aortae. Similar results were obtained after in vitro incubation with LPS. Endothelium removal or NOS3 inhibition with the calmodulin inhibitor, W7, increased NOS activity in the aortae of portal vein-stenosed rats after LPS incubation. In conclusion, in aortae of portal vein-stenosed rats exposed to LPS, no further decrease in aortic reactivity to phenylephrine was observed, and the induction of NOS2 was down-regulated. Endothelium removal or calmodulin inhibition inhibits NOS3 overactivity and leads to normalized NOS2 activation after LPS in aortae from portal vein-stenosed rats.
- Published
- 1999
- Full Text
- View/download PDF
45. [Toxicity of cholestatic bile acids on intrahepatic biliary cells of the rat].
- Author
-
Diallo A, Dumont M, Faye B, Poirel O, and Erlinger S
- Subjects
- Animals, Bile Ducts, Intrahepatic cytology, Cell Death drug effects, Keratins analysis, Ligation, Lithocholic Acid toxicity, Rats, Rats, Sprague-Dawley, Taurolithocholic Acid toxicity, gamma-Glutamyltransferase analysis, Bile Acids and Salts toxicity, Bile Ducts, Intrahepatic drug effects, Cholestasis metabolism
- Abstract
The aim of this study is: 1. to isolate intrahepatic biliary epithelial cells and, 2. to study the toxicity of cholestatic biliary acids on these cells. Cells were isolated from rats with proliferated bile duct-cells, that were induced by a 21 days bile duct ligation. They were characterized by glutamyltranspeptidase and cytokeratins 7 and 19 using histochemical or immuno cytochemical methods. Isolated cells were incubated with different concentrations (250, 500, 1000 and 2000 microM) of cholestatic biliary acids, lithocholate sulfate (LCS) and taurolithocholate sulfate (TLCS. Cells viability is estimated by three methods: Trypan blue, LDH release and MTT test. We obtained purified fractions of non parenchymal liver cells enriched in biliary epithelial cells (> 95%). On these cells, we showed toxicity of LCS and TLCS and determined CI 10 and CI 50 of these acids which were respectively 800 microM and 2 mM for LCS; 1.4 and 2 mM for TLCS. These results indicate that cholestatic biliary acids (LCS and TLCS) are toxic for biliary cells. This cytotoxicity can be probably a possible mechanism of cholestasis.
- Published
- 1994
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.